AFP
BSX icon

Ausdal Financial Partners’s Boston Scientific BSX Stock Holding History

Ausdal Financial Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
7,581
+3,570
+89% +$194K 0.01% 793
2026
Q1 		$252K Buy
4,011
+747
+23% +$59.8K 0.01% 853
2025
Q4 		$311K Buy
3,264
+384
+13% +$37.6K 0.01% 701
2025
Q3 		$281K Buy
+2,880
New +$298K 0.01% 760

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ausdal Financial Partners's BSX Position: Q2 2026 in Review

Ausdal Financial Partners increased its Boston Scientific (BSX) stake by 89% in Q2 2026, buying an estimated $194K and bringing the position to 7,581 shares worth $324K. The position accounts for 0.01% of the portfolio, ranked #793.

Ausdal Financial Partners first reported a position in BSX in Q3 2025 and has held it in 4 quarters since. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Ausdal Financial Partners held 7,581 shares of Boston Scientific worth $324K as of Q2 2026.
  • Ausdal Financial Partners bought 3,570 Boston Scientific shares in Q2 2026, an estimated $194K.
  • Boston Scientific made up 0.01% of Ausdal Financial Partners's portfolio in Q2 2026, its #793 holding.
  • Ausdal Financial Partners first reported a position in Boston Scientific in Q3 2025 and has held it in 4 quarters since.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Ausdal Financial Partners's 13F filing for Q2 2026, filed 14 Aug 2026.